Analyst upgrades, downgrades and initiations: ED, RTN, ALU, NSRGY, RTP, HPQ ...


Analyst upgrades:
  • Baird upgraded MSM Industrial (NYSE: MSM) to Outperform from Neutral based on valuation and a positive view for Industrial Distributors.
  • William Blair upgraded Allscripts (NASDAQ: MDRX) to Outperform from Market Perform on valuation following the recent pullback and believes Allscripts is well positioned to benefit from public policy that drives adoption of electronic medical records.
  • Citigroup upgraded Consolidated Edison (NYSE: ED) to Buy from Hold as they believe the ALJ recommendation in the company's pending electric rate case indicates potential for an improving outlook.
  • Raytheon (NYSE: RTN) was raised to Buy from Neutral at Goldman.
  • Smith & Nephew (NYSE: SNN) was upgraded at JP Morgan to Neutral from Underweight.
  • Becton Dickinson (NYSE: BDX) was upgraded to Overweight from Equal Weight at Morgan Stanley.
Analyst downgrades:
  • Oppenheimer downgraded Bio-Reference Labs (NASDAQ: BRLI) to Perform from Outperform as they believe weaker volumes could pressure top-line growth in the near-term. The firm lowered their target to $25 from $30.
  • Morgan Stanley downgraded shares of Alcatel-Lucent (NYSE: ALU) to Equal Weight from Overweight to reflect market deterioration as they find the risk/reward as balanced at current levels.
  • JP Morgan cut Nestle (OTC: NSRGY) to Underweight from Neutral on concerns the company's 2009 revenue will miss consensus estimates due to market share losses.
  • Rio Tinto (NYSE: RTP) and Anglo American (NASDAQ: AAUK) were lowered to Hold from Buy at Deutsche Bank.

  • PepsiAmericas (NYSE: PAS) was downgraded at Goldman to Sell from Neutral.
  • Stephens downgraded Home Bancshares (NASDAQ: HOMB) to Equal Weight from Overweight.
  • Analyst initiations:
    • Kaufman Bros. initiated Hewlett-Packard (NYSE: HPQ) with a Buy rating and $45 target. The firm is positive on the company's acquisition and integration of EDS and is modeling for above consensus EPS estimates.
    • Oppenheimer assumed Quest Diagnostics (NYSE: DGX) with a Perform rating and $47 target and believes weaker volumes from the current recession could pressure top line growth in the near-term.
    • Raymond James (NYSE: RJF) was started at Friedman Billings with a Market Perform rating and $19 target. The firm expects the company's banking and private client businesses to grow more slowly than in recent years given the current economic environment.
    • JMP Securities assumed CommVault (NASDAQ: CVLT) with an Outperform rating and $16 target.
    • Arch Coal (NYSE: ACI) and Alpha Natural (NYSE: ANR) were initiated with Hold ratings and targets of $22 and $23, respectively, at Citigroup.
    Symbol Lookup
    IndexesChangePrice
    DJIA-89.2312,801.23
    NASDAQ-23.352,903.88
    S&P 500-9.311,342.64

    Last updated: February 13, 2012: 05:44 AM

    Hot Stocks

    General Electric

    18.875-0.255(-1.33)

    Alcoa

    10.29-0.35(-3.29)

    Apple Inc

    493.42+0.25(+0.05)

    Google Inc 'A'

    605.91-5.55(-0.91)

    Bank of America

    8.07-0.11(-1.34)

    Wal-Mart Stores

    61.90-0.06(-0.10)

    Exxon Mobil Corp

    83.80-1.08(-1.27)

    Ford

    12.44-0.25(-1.97)

    Citigroup

    32.925-0.735(-2.18)

    IBM

    192.42-0.71(-0.37)

    Yahoo

    16.14+0.14(+0.88)

    Starbucks

    48.82-0.38(-0.77)

    Microsoft

    30.495-0.275(-0.89)

    Home Depot

    45.33+0.06(+0.13)

    DailyFinance Headlines

    Benzinga Headlines

    TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    DailyFinance BlackBerry App

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    BioHealth Investor Headlines

    Page Loaded in 1329129898772 ms.